Cleared Traditional

K123806 - FIBROSCAN

K123806 is an FDA 510(k) clearance for FIBROSCAN, manufactured by Echosens. The device is a Class 2 Radiology device with product code IYO cleared through the Traditional 510(k) pathway after a 116-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2013
Decision
116d
Days
Class 2
Risk

K123806 is an FDA 510(k) clearance for the FIBROSCAN. Classified as System, Imaging, Pulsed Echo, Ultrasonic (product code IYO), Class II - Special Controls.

Submitted by Echosens (Dedham, US). The FDA issued a Cleared decision on April 5, 2013 after a review of 116 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1560 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Echosens devices

FDA 510(k) Submission Details - K123806

510(k) Number K123806 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 10, 2012
Decision Date April 05, 2013
Days to Decision 116 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
9d slower than avg
Panel avg: 107d · This submission: 116d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

IYO Device Classification - Class 2, Special Controls

Product Code IYO System, Imaging, Pulsed Echo, Ultrasonic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IYO System, Imaging, Pulsed Echo, Ultrasonic

All 454
Devices cleared under the same product code (IYO) and FDA review panel - the closest regulatory comparables to K123806.
DIGITAL ULTRASONIC DIAGNOSTIC IMAGING SYSTEM
K131830 · Edan Instruments, Inc. · Sep 2013
UGEO PT60A DIAGNOSTIC ULTRASOUND SYSTEM
K132228 · Samsung Medison Co., Ltd. · Aug 2013
M7/M7T DIAGNOSTIC ULTRASOUND SYSTEM
K131690 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Jul 2013
ILAB ULTRASOUND IMAGING SYSTEM
K130243 · Boston Scientific Corp · Mar 2013
ILAB ULTRASOUND IMAGING SYSTEM
K123535 · Boston Scientific Corp · Jan 2013
VOLCANO S5/S5I INTRAVASCULAR ULTRASOUND IMAGING AND PRESSURE SYSTEM
K123898 · Volcano Corporation · Jan 2013